Filing Flows

Filing Flows › Microbot Medical (MBOT) › Who owns the stock

Who owns Microbot Medical (MBOT) stock

73 funds reported Microbot Medical (MBOT) shares in their latest 13F filings, worth $31.2M in all. The largest holder is Vanguard Group ($6.7M). Last quarter 31 funds added to their stakes and 28 cut them.

Largest holders of MBOT (13F)Largest holders of MBOT (13F)Vanguard Group$6.7MVanguard Capital Management LLC$5.7MCibc Private Wealth Group LLC$3.0MMitsubishi UFJ Asset Management$2.5MBlackRock$1.8MGeode Capital Management, LLC$1.6MUBS Group AG$1.6MDnB Asset Management AS$1.3MStifel Financial$1.2MMarshall Wace, LLP$1.1M

Largest holders (13F)

FundSharesValueChangeQuarter
Vanguard Group3,329,721$6.7Mincrease2025-12-31
Vanguard Capital Management LLC2,906,810$5.7Mdecrease2026-06-30
Cibc Private Wealth Group LLC1,480,000$3.0Mincrease2025-12-31
Mitsubishi UFJ Asset Management1,268,453$2.5Mnew2026-06-30
BlackRock902,411$1.8Mincrease2026-06-30
Geode Capital Management, LLC836,271$1.6Mincrease2026-06-30
UBS Group AG806,847$1.6Mdecrease2026-06-30
DnB Asset Management AS677,498$1.3Munchanged2026-06-30
Stifel Financial589,924$1.2Mincrease2026-06-30
Marshall Wace, LLP541,963$1.1Mincrease2026-06-30
Susquehanna International Group, LLP525,827$1.0Mdecrease2026-06-30
Vanguard Fiduciary Trust431,033$841Kincrease2026-06-30
State Street303,569$592Kunchanged2026-06-30
Northern Trust147,530$288Kincrease2026-06-30
Group One Trading LLC106,429$208Kincrease2026-06-30

Microbot Medical's latest quarter

Microbot Medical, Q2 2026: revenue $241K, net loss $5.6M, operating cash flow −$5.0M. The chart follows the revenue to costs, profit and cash.

Questions

Who owns the most MBOT stock?

By the latest 13F filings: Vanguard Group ($6.7M); Vanguard Capital Management LLC ($5.7M); Cibc Private Wealth Group LLC ($3.0M); Mitsubishi UFJ Asset Management ($2.5M); BlackRock ($1.8M).

What is the short interest in MBOT?

5,988,053 shares were sold short at the 2026-10-15 settlement, -9.8% of the float.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.